These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 32481684)

  • 1. Association between non-alcoholic fatty liver disease and the risk of pulmonary nodules in patients with intestinal polyps.
    Wu B; Zhang J; Chen Y; Chen S; Liu H
    J Thorac Dis; 2024 Jun; 16(6):3990-3999. PubMed ID: 38983169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Cytogenetic Alterations in Patients of Chronic Kidney Disease.
    Samarth RM; Tiwari RR; Modi G; Soni KK; Banjare ML; Ul Hasan S; Jain S
    Indian J Nephrol; 2023; 33(4):259-263. PubMed ID: 37781554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAFLD and risk of CKD.
    Sun DQ; Jin Y; Wang TY; Zheng KI; Rios RS; Zhang HY; Targher G; Byrne CD; Yuan WJ; Zheng MH
    Metabolism; 2021 Feb; 115():154433. PubMed ID: 33212070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease.
    Kaps L; Labenz C; Galle PR; Weinmann-Menke J; Kostev K; Schattenberg JM
    United European Gastroenterol J; 2020 Oct; 8(8):942-948. PubMed ID: 32698692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimorbidity patterns in the working age population with the top 10% medical cost from exhaustive insurance claims data of Japan Health Insurance Association.
    Nishida Y; Anzai T; Takahashi K; Kozuma T; Kanda E; Yamauchi K; Katsukawa F
    PLoS One; 2023; 18(9):e0291554. PubMed ID: 37768909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of metabolic dysfunction-associated fatty liver disease in kidney transplant recipients: A cross-sectional study using FibroScan.
    Yesil EE; Yilmaz Y; Yesil A; Mese M; Kaya E; Bakir EA
    Hepatol Forum; 2023 Jan; 4(1):14-18. PubMed ID: 36843889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver.
    Kaya E; Yilmaz Y
    J Clin Transl Hepatol; 2022 Apr; 10(2):329-338. PubMed ID: 35528971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astaxanthin Prevents Diet-Induced NASH Progression by Shaping Intrahepatic Immunity.
    Yang M; Kimchi ET; Staveley-O'Carroll KF; Li G
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid Disorders in NAFLD and Chronic Kidney Disease.
    Yang M; Geng CA; Liu X; Guan M
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic Fatty Liver Disease and the Kidney: A Review.
    Umbro I; Baratta F; Angelico F; Del Ben M
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Metabolic Associated Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study from NHANES 2017-2018.
    Deng Y; Zhao Q; Gong R
    Diabetes Metab Syndr Obes; 2021; 14():1751-1761. PubMed ID: 33911888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Risk Factors of Hyperuricemia in Patients with Chronic Kidney Disease and Non-Alcoholic Fatty Liver.
    Golmohammadi S; Tavasoli M; Asadi N
    Clin Exp Gastroenterol; 2020; 13():299-304. PubMed ID: 32903892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study.
    Park H; Dawwas GK; Liu X; Nguyen MH
    J Intern Med; 2019 Dec; 286(6):711-722. PubMed ID: 31359543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A brief review on the rising incidence of chronic kidney diseases and non-alcoholic fatty liver disease.
    Nagy J; Kovács T
    Physiol Int; 2019 Dec; 106(4):305-310. PubMed ID: 31906711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link?
    Targher G; Chonchol M; Zoppini G; Abaterusso C; Bonora E
    J Hepatol; 2011 May; 54(5):1020-9. PubMed ID: 21145850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Non-Alcoholic Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study.
    Akahane T; Akahane M; Namisaki T; Kaji K; Moriya K; Kawaratani H; Takaya H; Sawada Y; Shimozato N; Fujinaga Y; Furukawa M; Kitagawa K; Ozutsumi T; Tsuji Y; Kaya D; Mitoro A; Yoshiji H
    J Clin Med; 2020 May; 9(6):. PubMed ID: 32481684
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.